Tapemark

Tapemark

Pharmaceuticals, 1685 Marthaler Ln, West St. Paul, Minnesota, 55118, United States, 51-200 Employees

tapemark.com

  • twitter
  • LinkedIn

Who is TAPEMARK

Here at Tapemark, we are the foremost leaders and innovators for development and manufacturing in transdermal and oral thin film drug delivery. No, really, we are. We offer a fully-integr...

Read More

map
  • 1685 Marthaler Ln, West St. Paul, Minnesota, 55118, United States Headquarters: 1685 Marthaler Ln, West St. Paul, Minnesota, 55118, United States
  • 1952 Date Founded: 1952
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $100 Million to $250 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2679 | NAICS Code: 561110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from TAPEMARK

Tapemark Org Chart and Mapping

Employees

Kyle Jensen

Quality Control Analyst

Carol Swenson

Front Desk Coordinator

David Sutton

Manufacturing Operations,Safety and Security Manager

Mark Hebaus

Senior Project Manager

Phalla Long

Production Supervisor

Joseph Mezzetti

Vice President and General Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Tapemark

Answer: Tapemark's headquarters are located at 1685 Marthaler Ln, West St. Paul, Minnesota, 55118, United States

Answer: Tapemark's official website is https://tapemark.com

Answer: Tapemark's revenue is $100 Million to $250 Million

Answer: Tapemark's SIC: 2679

Answer: Tapemark's NAICS: 561110

Answer: Tapemark has 51-200 employees

Answer: Tapemark is in Pharmaceuticals

Answer: Tapemark contact info: Phone number: Website: https://tapemark.com

Answer: Here at Tapemark, we are the foremost leaders and innovators for development and manufacturing in transdermal and oral thin film drug delivery. No, really, we are. We offer a fully-integrated solution. Our services include formulation, optimization, blending, coating, converting, primary packaging, secondary cartoning, and kitting to commercially manufacture transdermal and oral thin film drugs. We have successful experience with NDA, ANDA, and 505(b)2 FDA approvals including those for Schedule I controlled substances. As a team of subject matter experts and craftsmen, we nurture our client's pharmaceutical formulation, develop it, scale it, and guide it through the FDA approval process. Tapemark is comprised of pioneering chemists, researchers, and engineers. As world experts in transdermal and oral thin film drug delivery, we offer full project management services to keep projects ahead of milestones and never behind. Tapemark has significant experience launching NDA and ANDA drugs to offer our clients the most hands-on and successful partnership in the CDMO space. Tapemark is known for its superior, truly unmatched, state-of-the-art equipment. Since the beginning, our investment has been laser-focused on owning and operating a 150,000-square-foot facility that cannot be beat in the industry. We are devoted to the industry's brightest people and most advanced equipment. We know what works. We know what doesn't. And we know where we can innovate and deliver for efficient FDA approvals and progressive timelines. The Tapemark team is powered, staffed, and driven to help clients move faster, better, and with unrivaled quality to benefit the patient and improve compliance. Our pharmaceutical products perform in the clinic and surpass FDA standards. Tapemark is privately-held and based in West St. Paul, Minnesota, with multiple facilities in a campus environment. The company services the pharmaceutical, medical, and consumer products markets.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access